Wilcock C, Chahwala S B, Hickman J A
Cancer Research Campaign Experimental Chemotherapy Group, Aston University, Birmingham, U.K.
Biochim Biophys Acta. 1988 Dec 22;946(2):368-78. doi: 10.1016/0005-2736(88)90412-9.
Incubation of L1210 murine leukemia cells in vitro with 10 microM of the bifunctional alkylating agent bis(2-chloroethyl)methylamine (nitrogen mustard, HN2) for 10 min brought about a fall of more than 99.9% in their ability to form colonies when the cells were suspended in 0.5% nutrient agar. Incubation with HN2 also inhibited the influx of the potassium congener 86Rb+ to exponentially proliferating L1210 cells in a concentration-dependent manner. This inhibition was specific and was accounted for by a reduction of a diuretic-sensitive component of 86Rb+ influx, identified in the preceding paper (Wilcock, C. and Hickman, J.A. (1988) Biochim. Biophys. Acta 946, 359-367) as being mediated by a Na+/K+/Cl- cotransporter. Inhibition by 10 microM HN2 was complete after a 3-h incubation. There was no inhibition at this time of the ouabain-sensitive component of 86Rb+ influx, mediated by Na+/K+-ATPase. After 3 h of incubation with 10 microM HN2 there was also no change in the membrane potential of the treated cells as measured by the distribution of the [3H]TPMP+, no decrease in cellular ATP concentration and no change in intracellular pH, and the ability of the cells to exclude the vital dye Trypan blue was not significantly different from control values. These effects of HN2, therefore, appeared to follow lethal damage, but precede cell death. In the stationary phase of L1210 cell growth, the component of HN2 and diuretic-sensitive K+ influx to L1210 cells was reduced, whilst the component constituting the HN2-insensitive ouabain-sensitive sodium pump was increased. The monofunctional alkylating agent MeHN1 (2-chloroethyldimethylamine) which cannot cross-link cellular targets and has no antitumor activity, did not inhibit 86Rb+ influx to L1210 cells when incubated at equimolar or equitoxic concentrations to HN2. Intracellular potassium concentration was maintained close to control values of 138 +/- 10 mM in HN2-treated cells because of an approx. 35% fall in cell volume. The results suggest that the Na+/K+/Cl- cotransporter is a selectively inhibitable target for HN2, and the lesion is discussed with reference to the cytotoxic effects of this agent.
将L1210小鼠白血病细胞与10微摩尔双功能烷化剂双(2-氯乙基)甲胺(氮芥,HN2)在体外孵育10分钟后,当细胞悬浮于0.5%营养琼脂中时,其形成集落的能力下降超过99.9%。用HN2孵育还以浓度依赖的方式抑制钾同系物86Rb+流入指数增殖的L1210细胞。这种抑制是特异性的,并且是由前一篇论文(Wilcock, C.和Hickman, J.A.(1988年)Biochim. Biophys. Acta 946, 359 - 367)中确定为由Na+/K+/Cl-协同转运蛋白介导的86Rb+流入的利尿敏感成分减少所致。10微摩尔HN2孵育3小时后抑制作用完全。此时由Na+/K+-ATP酶介导的86Rb+流入的哇巴因敏感成分没有受到抑制。用10微摩尔HN2孵育3小时后,经处理细胞的膜电位(通过[3H]TPMP+的分布测量)没有变化,细胞ATP浓度没有降低,细胞内pH没有变化,并且细胞排除活体染料台盼蓝的能力与对照值没有显著差异。因此,HN2的这些作用似乎发生在致死性损伤之后,但在细胞死亡之前。在L1210细胞生长的静止期,HN2和利尿敏感的K+流入L1210细胞的成分减少,而构成HN2不敏感的哇巴因敏感钠泵的成分增加。不能交联细胞靶点且无抗肿瘤活性的单功能烷化剂MeHN1(2-氯乙基二甲基胺),当以与HN2等摩尔或等毒性浓度孵育时,不会抑制86Rb+流入L1210细胞。由于细胞体积大约下降35%,HN2处理的细胞内钾浓度维持在接近138±10 mM的对照值。结果表明,Na+/K+/Cl-协同转运蛋白是HN2的一个可选择性抑制的靶点,并结合该药物的细胞毒性作用对损伤进行了讨论。